Adjunctive thrombectomy for acute myocardial infarction: A bayesian meta-analysis.

Area of Science:

• Cardiology
• Interventional Cardiology
• Medical Devices

Background:

• Adjunctive thrombectomy in acute myocardial infarction (MI) has shown limited impact on clinical outcomes despite improving reperfusion markers.
• Thrombectomy devices function by aspirating or mechanically fragmenting thrombus.
• Simple aspiration thrombectomy may offer specific advantages over other methods.

Purpose of the Study:

• To evaluate the efficacy of adjunctive thrombectomy in ST-segment elevation myocardial infarction (STEMI) reperfusion therapy.
• To compare outcomes of primary percutaneous coronary intervention with or without thrombectomy using Bayesian meta-analysis.
• To assess the specific impact of simple aspiration thrombectomy devices.

Main Methods:

• Bayesian meta-analysis of 21 eligible trials involving 4299 patients with STEMI.
• Randomized controlled trials comparing primary percutaneous coronary intervention with and without thrombectomy.
• Analysis focused on reperfusion markers (no-reflow, ST-segment resolution, TIMI/myocardial perfusion grade) and clinical outcomes (death, reinfarction, stroke).

Main Results:

• Thrombectomy significantly reduced no-reflow (OR, 0.39) and increased ST-segment resolution (OR, 2.22) and TIMI/myocardial perfusion grade 3 (OR, 2.50).
• No significant reduction was observed in death (OR, 0.94) or the composite of death, recurrent MI, or stroke (OR, 1.07).
• Simple aspiration thrombectomy specifically showed a positive effect on postprocedure TIMI grade 3 flow (OR, 1.49).

Conclusions:

• Adjunctive thrombectomy improves early reperfusion markers in STEMI but does not substantially affect 30-day clinical outcomes.
• Aspiration thrombectomy devices are not associated with reduced post-MI clinical outcomes.
• Thrombectomy remains an effective measure against no-reflow phenomenon in acute MI.